“Re-Do” Pricing Based on New Assumption Rather than Simple Cuts, DPP Lawmaker Says on Re-Pricing Rules

June 10, 2022
Democratic Party For the People Lawmaker Takanori Kawai Japan should not simply apply price slashes for drugs that saw better-than-expected market expansions or changes in main indications but should fundamentally “re-do” their pricing based on new assumptions and their innovative...read more